IPSC Competitors & Alternatives
Compare Century Therapeutics Inc with similar stocks in the same industry
Biotechnology
IPSC
Main Stock$2.02
Tradestie Score
50
Market Cap
$43.18M
Revenue Growth
-1.0%
Analyst Upside
+135.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$17.85
|
$448.32M | - | 56 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$27.27
|
$422.50M | - | 50 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$74.96
|
$410.79M | - | 49 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$10.07
|
$407.71M | - | 55 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$12.46
|
$386.68M | - | 52 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.87
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$11.74
|
$371.64M | - | 58 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$16.41
|
$354.45M | - | 55 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.43
|
$353.70M | - | 54 | Compare |
More IPSC Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry